Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort).
Tangui BarréMarc BourlièreClémence RamierFabrice CarratVincent Di BeoCamelia ProtopopescuFabienne MarcellinMorgane BureauCarole CagnotCéline DorivalFabien ZoulimJessica Zucman-RossiJean-Charles Duclos-ValléeHélène FontainePatrizia Carrierinull The Anrs/Afef Hepather Study GroupPublished in: Journal of clinical medicine (2022)
In people chronically infected with HCV, cannabis use was associated with a lower risk of hypertension and a lower number of metabolic disorders. Post-HCV cure studies are needed to confirm these findings using longitudinal data and to test whether they translate into reduced mortality in this population.